COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR PEYRONIE'S DISEASE: NO NEED TO POSTPONE, BUT NO NEED TO RUSH

被引:0
作者
Roshandel, R. [1 ]
Byrne, E. R. [1 ]
Alom, M. [1 ]
Helo, S. [1 ]
Kohler, T. S. [1 ]
Ziegelmann, M. J. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
263
引用
收藏
页数:1
相关论文
共 50 条
[41]   Collagenase Clostridium Histolyticum for the Treatment of Peyronie’s Disease: A ‘Real World’ Clinical Perspective [J].
James Anaissie ;
Wayne J. G. Hellstrom ;
Faysal A. Yafi .
Drugs, 2016, 76 :1523-1528
[42]   The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States [J].
Sun, Andrew J. ;
Li, Shufeng ;
Eisenberg, Michael L. .
WORLD JOURNAL OF MENS HEALTH, 2019, 37 (02) :234-239
[43]   IMPACT OF NUMBER OF CYCLES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ON OUTCOMES IN PATIENTS WITH PEYRONIE'S DISEASE [J].
Anaissie, James ;
Yafi, Faysal A. ;
Traore, Elizabeth J. ;
Sikka, Suresh C. ;
Hellstrom, Wayne J. G. .
JOURNAL OF UROLOGY, 2016, 195 (04) :E1061-E1061
[44]   Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men With Ventral Curvatures [J].
Alom, Manaf ;
Meng, Yifan ;
Sharma, Kiran Late ;
Savage, Joshua ;
Kohler, Tobias ;
Trost, Landon .
UROLOGY, 2019, 129 :119-124
[45]   Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature [J].
Masterson, Thomas A. ;
Rezk, Andrew ;
Ramasamy, Ranjith .
WORLD JOURNAL OF UROLOGY, 2020, 38 (02) :279-285
[46]   Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study [J].
Capece, M. ;
Cocci, A. ;
Russo, G. ;
Cito, G. ;
Giubilei, G. ;
Cacciamani, G. ;
Garaffa, G. ;
Falcone, M. ;
Timpano, M. ;
Tasso, G. ;
Sessa, F. ;
Campi, R. ;
Di Maida, F. ;
Cai, T. ;
Morelli, G. ;
Giammusso, B. ;
Verze, P. ;
Palmieri, A. ;
Ralph, D. ;
Mirone, V ;
Mondaini, N. .
ANDROLOGY, 2018, 6 (04) :564-567
[47]   PLAQUE CALCIFICATION DECREASES THE SUCCESS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE [J].
Wymer, K. ;
Ziegelmann, M. ;
Trost, L. .
JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02) :S26-S26
[48]   Intralesional collagenase Clostridium histolyticum in the management of Peyronie's disease: current best practice [J].
Cwikla, Daniel J. ;
Yafi, Faysal A. .
THERAPEUTIC ADVANCES IN UROLOGY, 2018, 10 (04) :139-153
[49]   Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie's disease: a safety profile [J].
Yan, Sylvia ;
Yap, Tet ;
Minhas, Suks .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (01) :123-126
[50]   CLINICAL OUTCOMES OF THE USE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) FOR PEYRONIE'S DISEASE (PD) [J].
Ignacio Martinez-Salamanca, Juan ;
Carballo, Natalia ;
Cerezo, Eugenio ;
Fraile, Agustin ;
Peinado, Francois ;
Fernandez Pascual, Esau ;
Carballido, Joaquin .
JOURNAL OF UROLOGY, 2017, 197 (04) :E756-E757